Violation Tracker Individual Record
Company:Fresenius Medical Care Holdings, Inc.
Date:October 9, 2019
Primary Offense:False Claims Act and related
Fresenius agreed to pay $5.2 million to resolve allegations that the company tested dialysis patients for Hepatitis B surface antigen more frequently than medically necessary and then billed Medicare for the unnecessary tests.
Level of Government:federal
Action Type:agency action
Agency:U.S. Attorney-District of Massachusetts
Civil or Criminal Case:civil
HQ Country of Parent:Germany
Ownership Structure of Parent:publicly traded
Major Industry of Parent:healthcare services
Specific Industry of Parent:healthcare services
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.